Pluri Inc. (PLUR) Insider Trading Activity

NASDAQ$3.055
Market Cap
$22.02M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
70 of 825
Rank in Industry
54 of 467

PLUR Insider Trading Activity

PLUR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$4,500,001
1
100
Sells
$0
0
0

Related Transactions

Manieu Alexandre Weinstein
1
$4.5M
0
$0
$4.5M

About Pluri Inc.

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Insider Activity of Pluri Inc.

Over the last 12 months, insiders at Pluri Inc. have bought $4.5M and sold $0 worth of Pluri Inc. stock.

On average, over the past 5 years, insiders at Pluri Inc. have bought $2.32M and sold $1.89M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Manieu Alexandre Weinstein () — $4.5M.

The last purchase of 976,139 shares for transaction amount of $4.5M was made by Manieu Alexandre Weinstein () on 2025‑04‑28.

List of Insider Buy and Sell Transactions, Pluri Inc.

2025-04-28PurchaseManieu Alexandre Weinstein
976,139
11.5449%
$4.61
$4.5M
-3.33%
2022-12-20SaleAberman Zamidirector
2,000
0.0062%
$0.97
$1,940
-19.19%
2022-02-10PurchaseAberman Zamidirector
80,616
0.4663%
$1.80
$145,109
-36.99%
2021-05-28SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
115,007
1.3749%
$3.72
$427,826
-32.34%
2021-05-27SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
95,885
1.137%
$3.69
$353,816
-31.97%
2021-05-26SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
144,678
1.7117%
$3.68
$532,635
-32.25%
2021-05-25SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
261,238
3.2238%
$3.84
$1M
-31.32%
2021-05-24SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
79,300
0.976%
$3.83
$303,719
-33.95%
2021-05-21SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
69,838
0.8932%
$3.98
$277,955
-35.17%
2021-05-03SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
23,721
0.3263%
$4.28
$101,526
-37.50%
2021-04-30SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
166,004
2.486%
$4.66
$773,579
-37.03%
2020-11-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.6234%
$9.70
$194,000
-60.93%
2020-10-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
50,000
1.5281%
$9.51
$475,500
-54.05%
2020-10-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.5913%
$9.20
$184,000
-53.92%
2020-09-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
139,006
4.619%
$10.34
$1.44M
-54.65%
2020-09-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
60,123
1.8858%
$9.76
$586,800
-52.72%
2020-09-28PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
13,189
0.4022%
$9.49
$125,164
-49.42%
2020-09-24PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
34,800
1.0087%
$9.02
$313,896
-45.34%
2020-09-23PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
10,734
0.3117%
$9.04
$96,983
-46.14%
2020-07-31PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
14,536
0.4405%
$9.43
$137,074
-28.67%
Total: 115
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Manieu Alexandre Weinstein
931246
12.9223%
$2.84M10
YANAY YAKYCo-CEO & President
4253045
59.0166%
$12.99M117
+5.96%
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
3121918
43.3207%
$9.54M288
<0.0001%
MERETSKI SHAI10 percent owner
2400000
33.3032%
$7.33M10
Aberman Zamidirector
1491973
20.7031%
$4.56M138
+1.24%
BRAUN ISAACdirector
636208
8.8282%
$1.94M10
<0.0001%
GERMAIN MARKdirector
513944
7.1317%
$1.57M05
SHORRER DORONdirector
464744
6.4489%
$1.42M31
+30.14%
BEN-YORAM ISRAELdirector
387235
5.3734%
$1.18M712
+7.11%
Kwiat Moriadirector
373571
5.1838%
$1.14M12
<0.0001%
ROSMAN NACHUMdirector
222964
3.0939%
$681,155.0205
Gur-Lavie BoazChief Financial Officer
59228
0.8219%
$180,941.5410
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Pluri Inc.
(PLUR)
$14,315,062
61
-6.21%
$22.02M
$6,204,522
45
1.91%
$22.34M
$95,303,339
30
-13.78%
$27.62M
$555,628
21
43.52%
$17M
$1,616,354
20
-12.22%
$18.47M
$112,810,270
18
-1.20%
$15.76M
$39,336,371
14
-17.87%
$31.05M
$28,281,140
14
18.42%
$16.92M
$15,724,108
9
124.63%
$28.85M
$149,996
5
16.26%
$21.62M
$147,504
5
-36.70%
$22.83M
$87,925
5
-18.56%
$24.62M
$1,184,658
4
-22.17%
$16.98M
$4,256,958
4
22.95%
$29.77M
$14,530
3
62.23%
$16.74M
$245,940
2
31.12%
$18.46M
$30,190
1
-42.39%
$17.82M
$500,000
1
-22.94%
$23.42M
$5,512,500
1
-7.91%
$30.35M

PLUR Institutional Investors: Active Positions

Increased Positions4+16%6,694+8.71%
Decreased Positions7-28%31,562-41.07%
New Positions2New95New
Sold Out Positions4Sold Out31,087Sold Out
Total Postitions22-12%51,979-32.36%

PLUR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Renaissance Technologies Llc$111.000.38%33,925+6,505+23.72%2025-09-30
Values First Advisors, Inc.$39.000.13%11,907-217-1.79%2025-09-30
Morgan Stanley$10.000.04%3,177+94+3.05%2025-09-30
Eversource Wealth Advisors, Llc$7.000.02%2,00000%2025-09-30
Wells Fargo & Company/Mn$1.00<0.01%18500%2025-09-30
Zurcher Kantonalbank (Zurich Cantonalbank)$0<0.01%13600%2025-09-30
Jpmorgan Chase & Co$0<0.01%12500%2025-09-30
Royal Bank Of Canada$0<0.01%12500%2025-09-30
Td Waterhouse Canada Inc.$0<0.01%9300%2025-09-30
Quent Capital, Llc$0<0.01%57+57New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.